1)T/HRBCL富于T细胞/组织细胞的B细胞淋巴瘤
1.T-cell/histiocyte-rich B-cell lymphoma (T/HRBCL) is an uncommon morphologic variant of diffuse large B-cell lymphoma (DLBCL).富于T细胞/组织细胞的B细胞淋巴瘤(T/HRBCL)是一种少见的非霍奇金淋巴瘤,其特征表现为大量反应性增生的小淋巴细胞和/或组织细胞中有散在分布的大细胞。
英文短句/例句
1.Micronodular T-cell/histiocyte-rich B-cell Lymphoma in Spleen: Study of the Immunophenotype and Gene Rearrangement脾脏微结节性富于T细胞/组织细胞的B细胞淋巴瘤—免疫表型及基因重排研究
2.Diffuse Large B-cell Lymphoma and Mucosa-Associ-ated Lymphoid Tissue Lymphoma:A CT Comparison Study胃弥漫大B细胞淋巴瘤与黏膜相关淋巴组织淋巴瘤CT比较研究
3.T Cell Receptor Gamma Gene Rearrangements in Mycosis Fougoides and B Cell Lymphoma;蕈样肉芽肿和B细胞淋巴瘤T细胞抗原受体γ基因重排的研究
4.cytotoxic T lymphocyte细胞毒性T淋巴细胞
5.Histogenesis of the mesenteric lymph nodes and development of related T and B cells in human fetus人胎肠系膜淋巴结组织发生及相关T、B细胞的发育
6.The Clinical Analysis of Angioimmunoblastic T-cell Lymphoma血管免疫母细胞性T细胞淋巴瘤的临床分析
7.Of or relating to lymph or the lymphatic tissue where lymphocytes are formed.淋巴的，淋巴细胞的淋巴、生成淋巴细胞的淋巴组织的或与之有关的
8.Anaplastic large cell lymphoma,lymphohistiocytic variant:report of 2 ALK~+ children and review of literatures儿童ALK阳性的淋巴组织细胞型间变性大细胞淋巴瘤临床病理分析
9.Study on Molecular Cytogenetic Abnormalities in B-lineage Lymphoid MalignanciesB淋巴细胞肿瘤分子细胞遗传学异常的研究
10.The Expression and Significance of Matrix Metalloproteinase-9 and Latent Membrane Protein-1 in Nasal NK/T Cell Lymphoma;MMP-9、LMP-1在鼻NK/T细胞淋巴瘤组织中的表达及意义
11.Pulmonary Primary Small B-cell Lymphoma of Mucosa-Associated Lymphoid Tissue:A clinicopathologic analysis原发性肺黏膜相关淋巴组织B细胞淋巴瘤临床病理分析
12.Dendritic Cells Transfected with Immunoglobulin Heavy Chain Variable Gene Framework Region Vaccine Can Induce Anti B-cell Malignance CTL Response;IgHV框架区DNA疫苗体外转染树突细胞诱导抗B淋巴瘤的细胞毒T细胞
13.Ontogeny of B Cells and Cloning of TCR Genes for Mandarin Fish Siniperca Chuatsi;鳜B淋巴细胞的发生和T淋巴细胞受体基因的克隆
14.Inhibition of T Lymphocyte Culture Supernatant Post Infection SIVmac239 on Macques B Lymphocyte(MM133) Proliferation in VitroSIVmac239感染T淋巴细胞后的上清液对B淋巴细胞增殖的抑制
15.A study on the proliferative activity of nasal NK/T-cell lymphoma鼻型NK/T细胞淋巴瘤增生活性的研究
16.Systemic review on progress of drug therapy for peripheral T-cell lymphoma外周T细胞淋巴瘤化疗的回顾及进展
17.Tissue factor expression in vascular endothelial cells induced by allogeneic T cells异基因T淋巴细胞诱导血管内皮细胞组织因子的表达
18.Human cytotoxic T lymphocyte responses specific to the DNA vaccine of Wilms' tumor gene product肾母细胞瘤免疫治疗中的细胞毒T淋巴细胞效应
相关短句/例句
T cell rich B cell lymphoma富于T细胞的B细胞淋巴瘤
1.Objective To study the histopathological features of T cell rich B cell lymphoma(TCRBCL).目的 研究富于T细胞的B细胞淋巴瘤 (TCRBCL)的病理形态特点、免疫组化诊断与鉴别诊断意义。
3)T-cell/histocyte-rich富于T细胞/组织细胞
1.Micronodular T-cell/histocyte-rich B-cell lymphoma in spleen:a study of immunophenotype and gene rearrangement;脾脏微结节性富于T细胞/组织细胞的B细胞淋巴瘤免疫表型及基因重排分析
4)T and B lymphocytesT、B淋巴细胞
5)T-cell lymphomaT细胞淋巴瘤
1.Subcutaneous panniculitis-like T-cell lymphoma:new concept in WHO-EORTC classification forcutaneous lymphomas;皮下脂膜炎样T细胞淋巴瘤WHO-EORTC皮肤淋巴瘤分类的新概念
2.Objective To determine the mutations of exons 5, 6, 7 and 8 of p53 gene and the alteration of microsatellite DNA around it, and investigate their relationship in T-cell lymphoma.目的探讨T细胞淋巴瘤p53突变和其周围微卫星DNA的改变及两者的关系,以进一步研究T细胞淋巴瘤的分子遗传学发病机制。
3.In order to investigate the ultrastructural features of malignant T cell (MTC) in bona marrow aspirate (BMA) from patients with T Cell Lymphoma, the antigen expression of MTC was analyzed by flow cytometry, and the ultrastructural features of MTC in BMA from 13 T-cell lymphoma patients with bone marrow involvement (BMI) were observed by transmission electron microscopy.为了研究T细胞淋巴瘤患者骨髓中恶性T细胞(malignantTcell,MTC)的超微结构,用流式细胞术分析13例T细胞淋巴瘤患者骨髓浸润MTC抗原表达,电子显微镜观察MTC的形态结构。
6)NK/T cell lymphomaNK/T细胞淋巴瘤
1.Expression profile of nasal NK/T cell lymphoma by cDNA microarray;人鼻腔NK／T细胞淋巴瘤基因表达谱的建立与分析
2.Nasal NK/T cell lymphoma:a report of 11 cases;鼻NK/T细胞淋巴瘤11例临床分析
3.The clinicopathologic?immunophenotypic features of NK/T cell lymphomas and their association with EBV;NK/T细胞淋巴瘤的临床病理、免疫表型及其与EB病毒的相关性
延伸阅读
抗淋巴细胞球蛋白 , 抗淋巴细胞免疫球蛋白,抗人胸腺淋巴细胞球蛋白药物名称：抗淋巴细胞球蛋白英文名：Antilymphocyte Globulin别名：抗淋巴细胞球蛋白 , 抗淋巴细胞免疫球蛋白,抗人胸腺淋巴细胞球蛋白外文名：Antilymphocyte Globuli ,ALG适应症： 1.适用于器官移植时的抗免疫排异治疗。用于人的同种异体移植有明显疗效，特别是对肾脏移植的病人。但也有一定局限性，主要是对急性排异期有效，对体液免疫所致的超急性排异无效。与硫唑嘌呤、泼尼松合用可提高脏器移植的成功率。骨髓移植时，供者与受者双方在术前均给以抗淋巴细胞球蛋白，有防止移植物抗宿主反应的作用。 2.自身免疫性疾病。ＡＬＧ对肾小球肾炎、红斑狼疮、类风湿性关节炎、重症肌无力等自身免疫性疾病有良好疗效，对顽固性皮炎、脉管炎、原发性肝炎、交感性眼炎等也有一定疗效 用量用法： 肌注：马ＡＬＧ每次每千克体重４～２０ｍｇ，兔ＡＬＧ每次每千克体重０．５～１ｍｇ，１日１次或隔日１次，１４日为１疗程。 静注：马ＡＬＧ每次每千克体重７～２０ｍｇ，稀释于５０～１００ｍｌ等渗盐水中，于４～６小时内滴完，输入适量等渗盐水，１日１次。 注意事项： 1.肌注可引起局部疼痛、红肿、发热、荨麻疹等，甚至有过敏性休克，静注也可有短时高热（３８～４０℃，持续３小时）、发冷，有时伴有关节痛和气短。静滴可见一过性体温升高与寒颤、低血压、心率增快等。一般在１～２小时内消退。 2.过敏体质者禁用，有急性感染者慎用。 3.采用ＡＬＧ治疗自身免疫性疾病应特别慎重，因长期应用使机体的免疫监管功能降低，给癌变细胞的发展以可乘之机。规格：冻干粉针剂:25mg(5ml)类别：免疫抑制剂
